JP2017527544A5 - - Google Patents

Download PDF

Info

Publication number
JP2017527544A5
JP2017527544A5 JP2017506827A JP2017506827A JP2017527544A5 JP 2017527544 A5 JP2017527544 A5 JP 2017527544A5 JP 2017506827 A JP2017506827 A JP 2017506827A JP 2017506827 A JP2017506827 A JP 2017506827A JP 2017527544 A5 JP2017527544 A5 JP 2017527544A5
Authority
JP
Japan
Prior art keywords
antigen
antibody
binding fragment
chain variable
variable region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017506827A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017527544A (ja
JP6670297B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/044144 external-priority patent/WO2016022883A1/en
Publication of JP2017527544A publication Critical patent/JP2017527544A/ja
Publication of JP2017527544A5 publication Critical patent/JP2017527544A5/ja
Application granted granted Critical
Publication of JP6670297B2 publication Critical patent/JP6670297B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017506827A 2014-08-07 2015-08-07 抗セラミド抗体 Active JP6670297B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462034453P 2014-08-07 2014-08-07
US62/034,453 2014-08-07
PCT/US2015/044144 WO2016022883A1 (en) 2014-08-07 2015-08-07 Anti-ceramide antibodies

Publications (3)

Publication Number Publication Date
JP2017527544A JP2017527544A (ja) 2017-09-21
JP2017527544A5 true JP2017527544A5 (https=) 2018-09-13
JP6670297B2 JP6670297B2 (ja) 2020-03-18

Family

ID=55264608

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017506827A Active JP6670297B2 (ja) 2014-08-07 2015-08-07 抗セラミド抗体

Country Status (12)

Country Link
US (4) US10450385B2 (https=)
EP (2) EP4681733A3 (https=)
JP (1) JP6670297B2 (https=)
KR (1) KR102296416B1 (https=)
CN (1) CN107074949B (https=)
AU (1) AU2015300902B2 (https=)
CA (1) CA2957415C (https=)
IL (1) IL250374B (https=)
MX (1) MX391141B (https=)
RU (1) RU2717651C2 (https=)
SG (1) SG11201700787XA (https=)
WO (1) WO2016022883A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10537633B2 (en) 2016-03-04 2020-01-21 Jn Biosciences Llc Antibodies to TIGIT
CA3048224A1 (en) 2016-12-23 2018-06-28 Bluefin Biomedicine, Inc. Anti-sez6l2 antibodies and antibody drug conjugates
WO2020231629A1 (en) 2019-05-16 2020-11-19 Snake River Bioscience, Inc. Compositions and methods for the treatment of major depressive disorder
JP7623706B2 (ja) * 2019-06-06 2025-01-29 ジャコバイオ ファーマスーティカルズ カンパニー リミテッド Cd73に特異的な結合分子と結合分子の使用
US10975169B1 (en) 2019-09-27 2021-04-13 Memorial Sloan Kettering Cancer Center Methods for treating diabetic retinopathy using anti-ceramide monoclonal antibody 2A2
KR102245082B1 (ko) * 2020-02-14 2021-04-26 단국대학교 천안캠퍼스 산학협력단 치주인대전구세포 표면에 특이적으로 결합하는 두 가지 IgG 타입 단일클론항체 LG43, LG73 및 그의 용도
CN115811987A (zh) * 2020-03-18 2023-03-17 纪念斯隆凯特琳癌症中心 抗神经酰胺抗体
MX2022015157A (es) 2020-06-02 2023-01-16 Arcus Biosciences Inc Anticuerpos para tigit.
EP4308231A4 (en) * 2021-03-16 2025-01-29 Memorial Sloan Kettering Cancer Center IMPROVING WOUND HEALING WITH ANTI-CERAMIDE ANTIBODIES
WO2024226646A2 (en) * 2023-04-25 2024-10-31 Memorial Sloan-Kettering Cancer Center Dlk1 -targeting antibodies and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
JPH02128697A (ja) * 1988-11-09 1990-05-17 Hoechst Japan Ltd 抗フコシルセラミドモノクローナル抗体
US7897753B2 (en) 2002-02-20 2011-03-01 Sirna Therapeutics, Inc. RNA interference mediated inhibition of XIAP gene expression using short interfering nucleic acid (siNA)
RU2310393C1 (ru) 2006-02-16 2007-11-20 ФГУ Научно-исследовательский институт по изучению лепры Федерального агентства по здравоохранению и социальному развитию Российской Федерации Способ прогнозирования обострений лепрозных невропатий у больных лепрой
JP5924863B2 (ja) * 2007-05-06 2016-05-25 スローン ケタリング インスティテュート フォア キャンサー リサーチ Gi症候群及び移植片対宿主病を治療及び予防する方法
US9163091B2 (en) 2007-05-30 2015-10-20 Lpath, Inc. Compositions and methods for binding lysophosphatidic acid
WO2009154026A1 (ja) * 2008-06-20 2009-12-23 国立大学法人岡山大学 石灰化小球に対する抗体及びその用途
KR101050829B1 (ko) 2008-10-02 2011-07-20 서울대학교산학협력단 항 pd-1 항체 또는 항 pd-l1 항체를 포함하는 항암제
CN102459335B (zh) * 2009-04-17 2015-11-25 伊缪纳斯制药株式会社 特异性结合Aβ寡聚体的抗体及其用途
FR2971250A1 (fr) * 2011-02-07 2012-08-10 Univ Nantes Anticorps anti-gb3 utiles dans le traitement des maladies associees a l'angiogenese
KR101256351B1 (ko) 2011-11-22 2013-04-19 김석진 필터 삽입공을 갖는 카메라 후드
WO2013125654A1 (ja) * 2012-02-21 2013-08-29 東レ株式会社 癌の治療及び/又は予防用医薬組成物
AU2013266069B2 (en) * 2012-05-25 2018-03-15 Sloan Kettering Institute For Cancer Research Methods for treating GI syndrome and graft versus host disease
CN115811987A (zh) * 2020-03-18 2023-03-17 纪念斯隆凯特琳癌症中心 抗神经酰胺抗体

Similar Documents

Publication Publication Date Title
JP2017527544A5 (https=)
JP2011514150A5 (https=)
HRP20200767T1 (hr) Humanizirana anti-humana cd19 protutijela i postupci uporabe
JP2018500014A5 (https=)
JP2014158469A5 (https=)
JP2017507652A5 (https=)
JP2016512551A5 (https=)
JP2018527919A5 (https=)
RU2016100892A (ru) Антитела против tweakr и их применение
JP2017528476A5 (https=)
JP2014511179A5 (https=)
JP2018513149A5 (https=)
RU2017119543A (ru) Анти-tim3 антитела и способы их применения
JP2016507470A5 (https=)
HRP20221471T1 (hr) Protutijela anti-fgfr3 i postupci za njihovu uporabu
RU2018129874A (ru) Антитела против фактора свертывания xi
JP2015520758A5 (https=)
RU2017123549A (ru) Антитела, нацеленные на антиген созревания в-клеток, и способы их применения
JP2019505527A5 (https=)
JP2015525795A5 (https=)
JP2016538832A5 (https=)
RU2016137110A (ru) Антитела к компоненту комплемента с5
JP2014205674A5 (https=)
JP2017502695A5 (https=)
RU2016114074A (ru) Анти-rspo антитела и способы применения